Speakers

Dr. Sonia T. Oskouei is the Vice President & U.S. Head of Biosimilars and Specialty for Sandoz, where she is responsible for leading commercialization and strategy for the biosimilars and specialty business. In her role, she focuses on maximizing the value of biosimilars to enhance patient access to critical therapies, while lowering the costs of high-quality care.

Dr. Oskouei is a seasoned healthcare executive with multiple leadership positions held across the healthcare value chain and holds distinguished expertise in biosimilars and the US healthcare system. Prior to joining Sandoz, Dr. Oskouei served as Vice President of Biosimilars at Cardinal Health, one of the nation’s largest healthcare services companies, where she leveraged an enterprise perspective to enable biosimilar adoption across the US. Prior to Cardinal Health, Dr. Oskouei served as the Vice President of Innovation and Digital Health at Premier Inc. Within the provider-led organization, she also led Premier’s national biosimilars strategy on behalf of 4,000 hospitals and 175,000 other provider types.

Dr. Oskouei is an established thought leader with numerous publications, experience engaging with the FDA and has served as a Board Advisor to industry leading healthcare organizations. Earlier in her career, Dr. Oskouei oversaw pharmacy purchasing and procurement for Novant Health, a four-state Integrated Delivery Network.

Dr. Oskouei received her Doctor of Pharmacy from Belmont University. In addition to her training as a PharmD, Dr. Oskouei completed post-graduate residencies in Clinical Pharmacy and Health System Pharmacy Administration & Leadership, is a Board-Certified Medical Affairs Specialist, and a Diplomate of the American Society of Health-System Pharmacists Leadership Academy.